Repligen
RGEN
#2039
Rank
S$12.09 B
Marketcap
S$214.78
Share price
-0.46%
Change (1 day)
7.22%
Change (1 year)
Categories

Repligen (RGEN) - Cash on Hand

Cash on Hand as of September 2025 : S$0.97 Billion

According to Repligen 's latest financial reports the company has S$0.97 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$1.02 B3.75%
2023-12-31S$0.99 B18.66%
2022-12-31S$0.83 B2.44%
2021-12-31S$0.81 B-13.98%
2020-12-31S$0.94 B33.21%
2019-12-31S$0.71 B169.03%
2018-12-31S$0.26 B13.94%
2017-12-31S$0.23 B13.26%
2016-12-31S$0.20 B102.11%
2015-12-31S$0.10 B31.45%
2014-12-31S$77.23 M-1.07%
2013-12-31S$78.07 M59.39%
2012-12-31S$48.98 M
2011-03-31S$62.53 M-15.78%
2010-03-31S$74.24 M0.04%
2009-03-31S$74.21 M8.09%
2008-03-31S$68.66 M100.02%
2007-03-31S$34.32 M11.75%
2006-03-31S$30.71 M7.63%
2005-03-31S$28.54 M22.42%
2004-03-31S$23.31 M-14.96%
2003-03-31S$27.41 M-28.75%
2002-03-31S$38.47 M-11.46%
2001-03-31S$43.45 M-25.7%
2000-03-31S$58.48 M926.04%
1999-03-31S$5.69 M-24.95%
1998-03-31S$7.59 M50.23%
1997-03-31S$5.05 M-47.92%
1996-03-31S$9.7 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novavax
NVAX
S$0.98 B 1.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.91 B 97.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$1.44 B 48.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$17.50 B 1,704.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$4.59 B 373.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$21.38 B 2,103.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$19.41 B 1,901.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$0.18 B-80.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$38.37 M-96.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
S$0.26 B-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA